Yixuan Pan
Zhejiang Key Laboratory Of Smart Biomaterials
Hangzhou, 310058, China
Hangzhou, 310058, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Obinutuzumab May Be an Effective and Safe Option for Adult Minimal Change Disease and Focal Segmental Glomerulosclerosis Patients after Multitarget Therapy Including Rituximab.
Journal: American journal of nephrology
Published: August 14, 2024
In situ formed reactive oxygen species-responsive dipyridamole prodrug hydrogel: Spatiotemporal drug delivery for chemoimmunotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 24, 2024
Hydroxychloroquine Induces Remission for IgA Nephropathy With Mild to Moderate Proteinuria: A Single-Centered Retrospective Analysis.
Journal: Cureus
Published: January 30, 2024
Electrical stimulation induces anti-tumor immunomodulation via a flexible microneedle-array-integrated interdigital electrode.
Journal: Science bulletin
Published: May 01, 2023
A Bispecific Peptide-Polymer Conjugate Bridging Target-Effector Cells to Enhance Immunotherapy.
Journal: Advanced healthcare materials
Published: November 20, 2022
The significance of follow-up serum uric acid levels in predicting all-cause mortality and cardiovascular mortality in peritoneal dialysis patients.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Published: February 04, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026